Reminders for booster jab and repeat vaccination against COVID-19 Adults who have not yet had a booster jab or repeat vaccination against COVID-19 will receive a reminder letter from RIVM, starting Friday 8 July 2022.
SARS-CoV-2 infections rising less rapidly 39,283 positive COVID-19 tests were reported in the Netherlands last week*. That is an increase of 15% compared to the week before that. This means that the number of reported infections is still rising, but not as rapidly as in the previous weeks.
Operations postponed due to pandemic result in 320,000 healthy life years lost The COVID-19 pandemic caused over 305,000 operations to be postponed in 2020 and 2021 in the Netherlands.
Participation in National Immunisation Programme shows slight decrease Participation in the National Immunisation Programme has fallen slightly, showing a decrease of 1 to 2 percentage points.
Pressure drainage can be a cost-effective technology to reduce CO2 emissions in peatland areas Pressure drainage can in some cases help to reduce CO2 emissions in peatland areas. This intervention is very expensive and only cost-effective when it sufficiently reduces CO2 emissions.
Application of personalised medicine: opportunities and challenges Pharmacotherapy based on individual patient characteristics such as genetic makeup, offers many potential benefits towards more effective treatment of a patients’ disease.
Strict diet combats aging diseases Mice with a severe aging disease live three times longer if they eat thirty percent less. Moreover, they age much healthier than mice that eat as much as they want.
Improved protection against pertussis The international PERISCOPE project has been granted a 30 million Euro European subsidy in order to better map the immune response to pertussis infection and vaccination.
Risks of chemical substances to human health and the environment RIVM is developing methods to identify new and emerging risks of chemical substances to workers, consumers and the environment.
Use of other needles in Dutch Immunisation Programme as a precaution As a result of the EenVandaag broadcast regarding the safety of injection needles, and after consultation with the Dutch Inspection for Health Care (IGZ), RIVM advises against the use of needles so